Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Rifapentine

EU orphan designation number: EU/3/10/750   
Active ingredient: Rifapentine
Indication: Treatment of tuberculosis
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Orphan designation EMEA/OD/145/09 (2010)3835 of 09/06/2010
06/11/2012 Change of name and/or address of sponsor EMEA/OD/145/09